Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Fukuda

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 6, 2026
[Pediatric drug development: current landscape, challenges, and future directions]Chie Emoto, Tsuyoshi Fukuda
Drug Metabolism and Pharmacokinetics|December 20, 2013
Optimization of mycophenolic acid therapy using clinical pharmacometricsMin Dong, Tsuyoshi Fukuda, Alexander A Vinks
Therapeutic Drug Monitoring|June 17, 2016
Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant PatientsChie Emoto, Alexander A Vinks, Tsuyoshi Fukuda
Molecular and Cellular Neurosciences|January 12, 2011
Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephalyTsuyoshi Fukuda, Akinori Tokunaga, Reiko Sakamoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 27, 2016
Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to ChildrenDavid Hahn, Chie Emoto, Alexander A Vinks, et al.
British Journal of Clinical Pharmacology|August 11, 2015
The impact of CYP3A5*3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically-based pharmacokinetic modelChie Emoto, Tsuyoshi Fukuda, Raja Venkatasubramanian, et al.
European Journal of Clinical Pharmacology|May 21, 2003
No major difference in inhibitory susceptibility between CYP2C9.1 and CYP2C9.3Tadaaki Hanatani, Tsuyoshi Fukuda, Sachi Onishi, et al.
Intensive Care Medicine|April 23, 2013
Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsisYuko Shimamoto, Tsuyoshi Fukuda, Kazuhiko Tanaka, et al.
Biology of Reproduction|March 18, 2016
The Histone Demethylase FBXL10 Regulates the Proliferation of Spermatogonia and Ensures Long-Term Sustainable Spermatogenesis in MiceManabu Ozawa, Tsuyoshi Fukuda, Reiko Sakamoto, et al.
Drug Metabolism and Pharmacokinetics|October 30, 2007
Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphismMasanori Kubo, Toshiko Koue, Hiromi Maune, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 6, 2026
[Pediatric drug development: current landscape, challenges, and future directions]Chie Emoto, Tsuyoshi Fukuda
Drug Metabolism and Pharmacokinetics|December 20, 2013
Optimization of mycophenolic acid therapy using clinical pharmacometricsMin Dong, Tsuyoshi Fukuda, Alexander A Vinks
Therapeutic Drug Monitoring|June 17, 2016
Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant PatientsChie Emoto, Alexander A Vinks, Tsuyoshi Fukuda
Molecular and Cellular Neurosciences|January 12, 2011
Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephalyTsuyoshi Fukuda, Akinori Tokunaga, Reiko Sakamoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 27, 2016
Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to ChildrenDavid Hahn, Chie Emoto, Alexander A Vinks, et al.
British Journal of Clinical Pharmacology|August 11, 2015
The impact of CYP3A5*3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically-based pharmacokinetic modelChie Emoto, Tsuyoshi Fukuda, Raja Venkatasubramanian, et al.
European Journal of Clinical Pharmacology|May 21, 2003
No major difference in inhibitory susceptibility between CYP2C9.1 and CYP2C9.3Tadaaki Hanatani, Tsuyoshi Fukuda, Sachi Onishi, et al.
Intensive Care Medicine|April 23, 2013
Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsisYuko Shimamoto, Tsuyoshi Fukuda, Kazuhiko Tanaka, et al.
Biology of Reproduction|March 18, 2016
The Histone Demethylase FBXL10 Regulates the Proliferation of Spermatogonia and Ensures Long-Term Sustainable Spermatogenesis in MiceManabu Ozawa, Tsuyoshi Fukuda, Reiko Sakamoto, et al.
Drug Metabolism and Pharmacokinetics|October 30, 2007
Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphismMasanori Kubo, Toshiko Koue, Hiromi Maune, et al.
Pageof 12